IRadimed Corporation: A Quarter of Record-Breaking Growth and Success
The IRadimed Corporation has reported a quarter of record-breaking growth and success, with its Third Quarter 2026 financial results exceeding expectations. During the Q3 conference call, Roger Susi, President and Chief Executive Officer, proudly announced that the new 3870 MR IV pump launch had achieved everything the company had hoped for and more.
Notably, the ramping of production to meet the growing demand for the 3870 pump was a significant challenge. However, the hardworking teams at IRadimed were able to rise to the occasion, achieving an impressive 125% increase in production from Q2. This led to a 14% increase in quarterly revenue, reaching $24.2 million, and an 18% sequential increase from Q2.
The success of the 3870 pump launch was further evident in the company's sales performance. The sales team booked record numbers of both the 3880 monitor and 3870 pumps during Q3, demonstrating strong customer acceptance and building a comfortable backlog for Q4. In fact, the company is expecting another 50%+ growth in revenue from the new pump in Q4.
The company's earnings also saw significant improvement, with GAAP earnings reaching $0.51 per share and non-GAAP earnings reaching $0.55 per share, up from $0.41 and $0.46 respectively in Q2. The gross margin improved by two full points sequentially to 76%, a testament to the company's manufacturing and engineering teams' hard work.
IRadimed's field sales team also performed well, with monitor sales remaining strong and growing. In fact, record numbers of monitors were booked in both Q2 and Q3, demonstrating the company's ability to manage multiple product lines effectively.
The launch of the 3870 MR IV pump has also led to a significant number of hospital customers motivated to purchase the new pump in shorter timeframes, resulting in a growing backlog of pumps on the books. This gives the company confidence in its ability to forecast revenue for Q4 and beyond.
As Roger Susi noted during the conference call, "The job of ramping production of this complex electromechanical device at the rate achieved is a very difficult task, but our teams have really risen to the challenge."
